SLC38A9 Regulation Affects Hippocampal Neuronal Autophagy: A Potential Alzheimer's Therapeutic Approach by Suppressing Alzheimer's Disease‐Related Protein Deposition
CNS Neuroscience & Therapeutics · 2026-03 · 32 (3)
DOI: 10.1002/cns.70823 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 11.03.2026. Verfasst von Yixin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Huadong Hospital Affiliated to Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Hippocampus, Autophagy, Alzheimer Disease, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Leading Talent Program, Shanghai Municipal Health Commission Key Support Discipline Program.
Themen: Demenz
Abstract (Originalsprache)
Aims
Impaired autophagy‐mediated clearance of Alzheimer's disease (AD)‐related proteins is a critical event in AD pathogenesis. SLC38A9, a member of the Solute Carrier 38 family, acts as an arginine sensor and plays an important role in regulating autophagy. Although the activation of autophagy regulated by the SLC38A9 may have a mitigating effect on AD, this aspect still awaits further exploration.
Methods
APP/PS1 mouse models and HT22 cells treated with amyloid‐β 25–35 (Aβ 25–35 ) were transduced with vectors to evaluate the effect of SLC38A9 in AD.
Results
We show that decreasing SLC38A9 could promote the hippocampal neuronal autophagic clearance of AD‐related proteins, reduce neuronal apoptosis, and improve cognitive function.
Conclusion
Our results demonstrate SLC38A9 is involved in AD‐related pathology and its cognitive impairment, and may offer new therapeutic targets to AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
- Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai, China.
- Shanghai Institute of Geriatrics and Gerontology, Shanghai, China.
- Department of General Practice, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
ORCID-Profile: Yixin Chen, Xueying Ji
Förderung
- National Natural Science Foundation of China
- Shanghai Leading Talent Program
- Shanghai Municipal Health Commission Key Support Discipline Program
- China Youth Medical Innovation Research Project
Zitieren
APA
Chen, Y., Ji, X., Zhao, J., Bao, Z., & Huang, Y. (2026). SLC38A9 Regulation Affects Hippocampal Neuronal Autophagy: A Potential Alzheimer's Therapeutic Approach by Suppressing Alzheimer's Disease‐Related Protein Deposition. CNS Neuroscience & Therapeutics, 32(3). https://doi.org/10.1002/cns.70823
Vancouver
Chen Y, Ji X, Zhao J, Bao Z, Huang Y. SLC38A9 Regulation Affects Hippocampal Neuronal Autophagy: A Potential Alzheimer's Therapeutic Approach by Suppressing Alzheimer's Disease‐Related Protein Deposition. CNS Neuroscience & Therapeutics. 2026;32(3). doi:10.1002/cns.70823
BibTeX
@article{Chen2026,
author = {Chen, Yixin and Ji, Xueying and Zhao, Jiaxiu and Bao, Zhijun and Huang, Yiqin},
title = {SLC38A9 Regulation Affects Hippocampal Neuronal Autophagy: A Potential Alzheimer's Therapeutic Approach by Suppressing Alzheimer's Disease‐Related Protein Deposition},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {3},
doi = {10.1002/cns.70823}
}
EUVIMED